insitro

Raises and deals from press releases

• Deal AstraZeneca deal · $40M upfront · announced Oct 15, 2026 Company release ↗
  Source quote

  • Oct 15, 2026 · Company release ↗
    “Collaboration applies insitro’s Virtual Human causal AI discovery platform to two diseases defined by patient heterogeneity and high unmet medical need insitro to receive $40 million upfront and up to approximately $1.46 billion in potential discovery”
• Deal Bristol Myers Squibb deal · amount not disclosed · announced Mar 23, 2026 Company release ↗
  Source quote

  • Mar 23, 2026 · Company release ↗
    “– – insitro … the AI therapeutics company built on causal biology, today announced the expansion of its strategic collaboration with Bristol Myers Squibb (NYSE: BMY) to advance a broadened portfolio of therapeutic programs for amyotrophic lateral sclerosis (ALS).”
• Deal Bristol Myers Squibb deal · amount not disclosed · announced Oct 14, 2025 Company release ↗
  Source quote

  • Oct 14, 2025 · Company release ↗
    “— insitro … a pioneer in machine learning–driven drug discovery and development, and Bristol Myers Squibb (NYSE: BMY), today announced the next phase of their collaboration to discover new molecules with potential as new treatments for amyotrophic lateral sclerosis (ALS).”
• Deal Lilly deal · amount not disclosed · announced Sep 9, 2025 Company release ↗
  Source quote

  • Sep 9, 2025 · Company release ↗
    “– insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to develop advanced machine learning models that can accurately predict key pharmacological properties of small molecules”

From the company’s own releases; this list is partial. All raises and deals